Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Teijin said on August 19 that it has signed a technical advisory agreement with Dario Campana, a leading expert in cell therapies who has helped develop foundational technologies for CAR-T cell therapy. Teijin aims to draw on Campana’s expertise to…
To read the full story
Related Article
- Teijin, Shinshu University Link Arms on CAR-T Manufacturing
September 10, 2026
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





